dc.contributor.author | Madasu, M.K. | |
dc.contributor.author | Roche, Michelle | |
dc.contributor.author | Finn, David P. | |
dc.date.accessioned | 2019-03-29T11:56:52Z | |
dc.date.available | 2019-03-29T11:56:52Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Madasu, M.K., Roche, Michelle, & Finn, David P. (2015). Supraspinal Transient Receptor Potential Subfamily V Member 1 (TRPV1) in Pain and Psychiatric Disorders. In David P. Finn & Brian E. Leonard (Eds.), Pain in Psychiatric Disorders: Modern Trends Pharmacopsychiatry (Vol. 30, pp. 80-93). Basel: Karger. | en_IE |
dc.identifier.issn | 1662-4505 | |
dc.identifier.uri | http://hdl.handle.net/10379/15075 | |
dc.description.abstract | The transient receptor potential subfamily V member 1 (TRPV1) belongs to the diverse transient receptor potential (TRP) family of cation channels. It was first characterized in primary afferent fibres as a receptor for capsaicin. Peripheral TRPV1 has a very well-described role in nociception. However, TRPV1 is now recognized to have a broader distribution and function, with supraspinal/brain TRPV1 known to modulate pain processing. Recently, studies employing histological, genetic and pharmacological approaches have provided evidence that supraspinal TRPV1 also modulates brain neurobiology and behaviours related to anxiety, depression and schizophrenia. Key brain regions involved in TRPV1-mediated modulation of pain and affect include the periaqueductal grey, hippocampus and medial prefrontal cortex. Thus, TRPV1 in the brain is emerging as an important molecular substrate which is dually implicated in both pain and psychiatric disorders, and represents a novel therapeutic target for these conditions and their comorbidity. | en_IE |
dc.description.sponsorship | This work was funded by grants from Science Foundation Ireland (10/IN.1/B2976) and a PhD
Scholarship from the College of Science, National University of Ireland Galway. | en_IE |
dc.format | application/pdf | en_IE |
dc.language.iso | en | en_IE |
dc.publisher | Karger | en_IE |
dc.relation.ispartof | Pain in Psychiatric Disorders. Mod Trends Pharmacopsychiatry | en |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Ireland | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/ie/ | |
dc.subject | TRPV1 | en_IE |
dc.subject | Pain | en_IE |
dc.subject | Negative affective state | en_IE |
dc.subject | Periaqueductal grey | en_IE |
dc.subject | Capsaicin | en_IE |
dc.subject | Rat | en_IE |
dc.title | Supraspinal transient receptor potential subfamily V member 1 (TRPV1) in pain and psychiatric disorders | en_IE |
dc.type | Book chapter | en_IE |
dc.date.updated | 2019-03-27T13:40:23Z | |
dc.identifier.doi | 10.1159/000435934 | |
dc.local.publishedsource | https://doi.org/10.1159/000435934 | en_IE |
dc.description.peer-reviewed | Peer reviewed | |
dc.contributor.funder | Science Foundation Ireland | en_IE |
dc.contributor.funder | Irish Research Council | en_IE |
dc.contributor.funder | College of Science, National University of Ireland, Galway | en_IE |
dc.internal.rssid | 10575297 | |
dc.local.contact | David Finn, Dept. Of Pharmacology &, Therapeutics, Nui, Galway. 5280 Email: david.finn@nuigalway.ie | |
dc.local.copyrightchecked | yes | |
dc.local.version | ACCEPTED | |
dcterms.project | info:eu-repo/grantAgreement/SFI/SFI Principal Investigator Programme (PI)/10/IN.1/B2976/IE/The role of the endocannabinoid system in anxiety-induced modulation of pain: sites and mechanisms of action/ | en_IE |
nui.item.downloads | 491 | |